Optimizing Cardiovascular Risk Reduction in High-Risk Patients: Focus on Strategies to Improve Non-HDL-Cholesterol Goal Attainment

Abbott, ECS
11/19/20, 12:00 AM
Asia/Dubai GMT+4

Description

ENDORSED BY THE EMIRATES CARDIAC SOCIETY

Date: November 18, 2020

Timings:

21:00-22:40 (GMT +4 Abu Dhabi, Muscat Time)

 

Speakers: Dr. Michel Farnier and Dr. Julian Halcox

Moderator: Dr. Abdullah Shehab

 

21:00-21:40

Importance of Management of Non-HDL Cholesterol for Better CV Risk Management

Presented by Dr. Michel Farnier

 

21:40-22:20

How to Incorporate Highly Purified N-3 AEEs for Optimizing CVD Prevention in High Risk Patients

Presented by Dr. Julian Halcox

 

22:20-22:40

Q&A

Questions and Answers will open to the audience

 

Previous registration necessary?

NO

YES
Simultaneous translation ?

NO

YES
Will it be recorded?
NO
YES

Abdullah Shehab

Importance of Management of Non-HDL Cholesterol for Better CV Risk Management, How to Incorporate Highly Purified N-3 AEEs for Optimizing CVD Prevention in High Risk Patients, Q&A

Inglês

 

Speakers

Michel Farnier, Julian Halcox

 

Link to the Event

Banner to the Event

Optimizing Cardiovascular Risk Reduction in High-Risk Patients: Focus on Strategies to Improve Non-HDL-Cholesterol Goal Attainment